Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II: Use of solid-phase synthesis to explore novel statine motifs

Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II : Use of solid-phase synthesis to explore novel statine motifs

Picomolar to low nanomolar inhibitors of the two aspartic proteases plasmepsin (Plm) I and II, from the malaria parasite Plasmodium falciparum, have been identified from sets of libraries containing novel statine-like templates modified at the amino and carboxy terminus. The syntheses of the novel statine templates were carried out in solution phase using efficient synthetic routes and resulting in excellent stereochemical control. The most promising statine template was attached to solid support and diversified by use of parallel synthesis. The products were evaluated for their Plm I and II inhibitory activity as well as their selectivity over cathepsin D. Selected inhibitors were, in addition, evaluated for their inhibition of parasite growth in cultured infected human red blood cells. The most potent inhibitor in this report, compound 16, displays Ki values of 0.5 and 2.2 nM for Plm I and II, respectively. Inhibitor 16 is also effective in attenuating parasite growth in red blood cells showing 51% inhibition at a concentration of 5 μM. Several inhibitors have been identified that exhibit Ki values between 0.5 and 74 nM for both Plm I and II. Some of these inhibitors also show excellent selectivity vs cathepsin D.

Chen, YantaoLinköpings universitet,Kemi,Tekniska högskolan (author)
Belfrage, Anna KarinLinköpings universitet,Kemi,Tekniska högskolan(Swepub:liu)annbe31 (author)
Blackman, Michael JDivision of Parasitology, National Institute for Medical Research, London, United Kingdom (author)
Kvarnström, IngemarLinköpings universitet,Kemi,Tekniska högskolan(Swepub:liu)ingkv34 (author)
Jansson, KatarinaMedivir AB, Huddinge, Sweden (author)
Vrang, LottaMedivir AB, Huddinge, Sweden (author)
Hamelink, ElizabethMedivir AB, Huddinge, Sweden (author)
Hallberg, AndersUppsala universitet,Institutionen för läkemedelskemi,OrgFarmKemi,Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden(Swepub:uu)andehall (author)
Rosenquist, AsaLinköpings universitet,Kemi,Tekniska högskolan (author)
Samuelsson, BertilMedivir AB, Huddinge, Sweden and Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Stockholm, Sweden (author)
Linköpings universitetKemi (creator_code:org_t)

In:Journal of Medicinal Chemistry: American Chemical Society (ACS)47:13, s. 3353-33660022-26231520-4804

By the author/editor: Johansson, Per-O ...; Chen, Yantao; Belfrage, Anna K ...; Blackman, Michae ...; Kvarnström, Inge ...; Jansson, Katarin ...; show more...; Vrang, Lotta; Hamelink, Elizab ...; Hallberg, Anders; Rosenquist, Asa; Samuelsson, Bert ...; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.